Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

Clinical trial NCT00074737 · COMPLETED

Trial details

NCT number: NCT00074737
Sponsor: Eleos, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2004-04-01
Primary completion: 2007-05-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.